PHAR vs VRTX: Which Stock is Better?
Side-by-side comparison of Pharming Group Nv and Vertex Pharmaceuticals Inc in 2026
PHAR
Pharming Group Nv
$17.35
VRTX
Vertex Pharmaceuticals Inc
$435.65
Key Metrics Comparison
| Metric | PHAR | VRTX | Winner |
|---|---|---|---|
| Market Cap | $1.26B | $112.35B | VRTX |
| P/E Ratio | 445.00 | 28.81 | VRTX |
| EPS (TTM) | $0.04 | $15.33 | VRTX |
| Revenue Growth | 0.1% | 0.1% | PHAR |
| Gross Margin | 87.9% | 53.7% | PHAR |
Analyze PHAR
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or VRTX a better investment?
Comparing PHAR and VRTX: Pharming Group Nv has a market cap of $1.26B while Vertex Pharmaceuticals Inc has $112.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and VRTX?
PHAR (Pharming Group Nv) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or VRTX?
Based on P/E ratios, VRTX trades at a lower multiple (28.8x vs 445.0x).
Which is growing faster: PHAR or VRTX?
PHAR has higher revenue growth at 0.1% vs 0.1% for VRTX.
Which company is more profitable: PHAR or VRTX?
Pharming Group Nv (PHAR) has higher gross margins at 87.9% compared to 53.7% for VRTX.
Which is the larger company: PHAR or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.35B compared to $1.26B for PHAR.
Should I buy PHAR or VRTX in 2026?
Both PHAR and VRTX have investment merit. PHAR trades at $17.35 while VRTX trades at $435.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and VRTX stock?
Key differences: Market Cap ($1.26B vs $112.35B), P/E Ratio (445.0x vs 28.8x), Revenue Growth (0.1% vs 0.1%), Gross Margin (87.9% vs 53.7%).